Filing
Spy
Filing
Spy
Home
About
PCVX
Vaxcyte, Inc.
Clinical-stage vaccine company developing conjugate and novel protein vaccines
CUSIP: 92243G108
Healthcare
US
1 holder
Ownership
Activity
2025 Q1
4 of 8 quarters
Total Value
$45.62M
Total Shares
1.21M
Net Share Change
+6.2K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Maverick Capital
$45.62M
1.21M
0.8%
ADD
+6.2K
(+0.5%)
Maverick Capital
$45.62M
1.21M shares
ADD
+6.2K
(+0.5%)
PCVX — Vaxcyte, Inc. - FilingSpy